Department of Chemistry, Massachusetts Institute of Technology, 77 Massachusetts Ave, Cambridge, MA, 02139-4307, USA.
Curr Top Microbiol Immunol. 2018;414:1-25. doi: 10.1007/82_2017_56.
Cells address challenges to protein folding in the secretory pathway by engaging endoplasmic reticulum (ER)-localized protective mechanisms that are collectively termed the unfolded protein response (UPR). By the action of the transmembrane signal transducers IRE1, PERK, and ATF6, the UPR induces networks of genes whose products alleviate the burden of protein misfolding. The UPR also plays instructive roles in cell differentiation and development, aids in the response to pathogens, and coordinates the output of professional secretory cells. These functions add to and move beyond the UPR's classical role in addressing proteotoxic stress. Thus, the UPR is not just a reaction to protein misfolding, but also a fundamental driving force in physiology and pathology. Recent efforts have yielded a suite of chemical genetic methods and small molecule modulators that now provide researchers with both stress-dependent and -independent control of UPR activity. Such tools provide new opportunities to perturb the UPR and thereby study mechanisms for maintaining proteostasis in the secretory pathway. Numerous observations now hint at the therapeutic potential of UPR modulation for diseases related to the misfolding and aggregation of ER client proteins. Growing evidence also indicates the promise of targeting ER proteostasis nodes downstream of the UPR. Here, we review selected advances in these areas, providing a resource to inform ongoing studies of secretory proteostasis and function as they relate to the UPR.
细胞通过激活内质网(ER)定位的保护机制来应对分泌途径中蛋白质折叠的挑战,这些机制统称为未折叠蛋白反应(UPR)。通过跨膜信号转导蛋白 IRE1、PERK 和 ATF6 的作用,UPR 诱导了一系列基因网络的表达,这些基因的产物可以减轻蛋白质错误折叠的负担。UPR 在细胞分化和发育、帮助应对病原体以及协调专业分泌细胞的输出方面也具有指导作用。这些功能增加并超越了 UPR 在应对蛋白毒性应激方面的经典作用。因此,UPR 不仅仅是对蛋白质错误折叠的反应,也是生理学和病理学的基本驱动力。最近的努力产生了一系列化学遗传学方法和小分子调节剂,现在为研究人员提供了依赖应激和不依赖应激的 UPR 活性控制。这些工具为扰动 UPR 并研究维持分泌途径中蛋白质稳定性的机制提供了新的机会。现在有许多观察结果表明,UPR 调节在与 ER 客户蛋白错误折叠和聚集相关的疾病治疗方面具有潜力。越来越多的证据也表明,靶向 UPR 下游的 ER 蛋白稳态节点具有一定的前景。在这里,我们回顾了这些领域的一些进展,为正在进行的与 UPR 相关的分泌蛋白稳态和功能研究提供了信息资源。